marketcaparena
Search

    PAYS

    Paysign, Inc.

    Company overview

    Market capitalization
    $718.20M
    Employees
    226
    Latest publication
    2026-09-29
    About Paysign, Inc.

    Paysign, Inc. provides prepaid card programs, patient affordability offerings, digital banking, life science software technology solutions, and integrated payment processing services for businesses, consumers, and government institutions in the United States. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software solutions. It also operates a customer service center; and offers a communication suite, including mobile app, two-way SMS, text alerts, and cardholder web portal. It markets its prepaid card solutions under the Paysign brand name. The company serves companies and municipalities that require payment solutions for rewards, rebates, payment assistance, and other payments to their customers, employees, agents, and others. Paysign, Inc. was founded in 2001 and is headquartered in Henderson, Nevada.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue28,252,071USD28,038,424USD22,755,196USD21,596,478USD19,078,353USD18,598,149USD15,606,448USD15,256,431USD
    Cost Of Revenue10,355,048USD12,455,635USD11,841,902USD9,446,089USD7,323,188USD6,907,321USD6,407,442USD6,783,117USD
    Gross Profit17,897,023USD15,582,789USD10,913,294USD12,150,389USD11,755,165USD11,690,828USD9,199,006USD8,473,314USD
    Selling General Administrative8,546,278USD8,914,654USD9,059,079USD8,378,018USD8,197,461USD7,400,759USD6,546,768USD6,217,844USD
    Total Operating Expenses10,886,107USD8,914,654USD9,059,079USD10,568,438USD10,317,558USD9,201,762USD8,734,672USD7,783,465USD
    Operating Income7,010,916USD6,668,135USD1,854,215USD1,581,951USD1,437,607USD2,489,066USD464,334USD689,849USD
    Total Other Income Expense Net894,203USD800,863USD639,391USD663,666USD605,160USD762,198USD771,273USD800,715USD
    Depreciation And Amortization2,339,829USD2,636,156USD2,207,277USD2,120,097USD2,120,097USD1,801,003USD1,703,338USD1,565,621USD
    Income Before Tax7,905,119USD7,468,998USD2,493,606USD2,245,617USD2,042,767USD3,251,264USD1,235,607USD1,490,564USD
    Income Tax Expense1,148,582USD2,030,080USD1,130,989USD30,482USD655,006USD665,164USD-137,265USD53,727USD
    Net Income6,756,537USD5,438,918USD1,362,617USD2,215,135USD1,387,761USD2,586,100USD1,372,872USD1,436,837USD
    Interest Income—800,863USD639,391USD663,666USD605,160USD762,198USD771,273USD800,715USD
    Net Interest Income—800,863USD639,391USD663,666USD605,160USD762,198USD771,273USD800,715USD
    Tax Provision—2,030,080USD1,130,989USD30,482USD655,006USD665,164USD-137,265USD53,727USD
    Net Income From Continuing Ops—5,438,918USD1,362,617USD2,215,135USD1,387,761USD2,586,100USD1,372,872USD1,436,837USD
    Ebit—7,468,998USD2,493,606USD2,245,617USD2,042,767USD3,251,264USD1,235,607USD1,490,564USD
    Ebitda—10,105,154USD4,700,883USD4,365,714USD4,162,864USD5,052,267USD2,938,945USD3,056,185USD
    Reconciled Depreciation—2,636,156USD2,207,277USD2,190,420USD2,120,097USD1,801,003USD1,703,338USD1,565,621USD
    Unclassified Operating Expenses———2,190,420USD2,120,097USD1,801,003USD1,703,338USD1,565,621USD
    Selling And Marketing Expenses——————484,566USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue82,028,176USD58,384,552USD47,274,162USD38,033,667USD34,666,653USD23,423,675USD15,234,091USD10,416,672USD
    Cost Of Revenue41,630,020USD26,187,218USD23,137,997USD17,079,069USD15,425,178USD12,026,452USD8,534,272USD5,197,370USD
    Gross Profit40,398,156USD32,197,333USD24,136,165USD20,954,598USD19,241,475USD11,397,223USD6,699,819USD5,219,302USD
    Selling General Administrative33,035,317USD24,696,274USD20,098,336USD17,557,193USD11,490,741USD7,685,527USD4,055,836USD3,288,373USD
    Total Operating Expenses33,154,553USD31,175,826USD24,303,420USD20,610,263USD13,139,821USD8,924,595USD4,932,027USD3,860,693USD
    Operating Income7,243,603USD1,021,508USD-167,255USD344,335USD6,101,654USD2,472,628USD1,767,792USD1,358,609USD
    Interest Income2,670,415USD3,116,689USD2,241,458USD790,917USD441,116USD139,738USD0USD0USD
    Net Interest Income2,670,415USD3,116,689USD2,241,458USD790,917USD441,116USD139,738USD-31,623USD-77,107USD
    Income Before Tax10,033,254USD4,138,197USD2,363,816USD1,135,252USD6,542,770USD2,581,241USD1,791,710USD1,297,651USD
    Income Tax Expense2,481,641USD322,290USD-4,094,911USD107,477USD-909,976USD108,613USD6,000USD-103,148USD
    Tax Provision2,481,641USD322,290USD207,300USD107,477USD-909,976USD0USD6,000USD0USD
    Net Income7,551,613USD3,815,907USD6,458,727USD1,027,775USD7,454,319USD2,588,054USD1,791,141USD1,400,799USD
    Net Income From Continuing Ops7,551,613USD3,815,907USD1,549,413USD1,027,775USD7,452,746USD2,581,241USD1,785,710USD1,297,651USD
    Ebit10,033,254USD4,138,197USD2,363,816USD-115,420USD6,542,770USD2,472,628USD1,767,792USD1,358,609USD
    Ebitda18,352,051USD10,133,183USD6,390,394USD2,794,192USD8,025,910USD3,562,149USD2,643,983USD1,930,929USD
    Depreciation And Amortization8,318,797USD5,994,986USD4,026,578USD2,909,612USD1,483,140USD1,089,521USD876,191USD572,320USD
    Reconciled Depreciation8,318,797USD5,994,986USD3,626,572USD2,909,612USD1,483,140USD1,089,521USD876,191USD—
    Total Other Income Expense Net2,789,651USD3,116,689USD2,531,071USD790,917USD441,116USD108,613USD23,918USD-60,958USD
    Selling And Marketing Expenses—484,566USD178,506USD603,213USD165,940USD149,547USD——
    Unclassified Operating Expenses—5,994,986USD4,026,578USD2,449,857USD1,483,140USD1,089,521USD——
    Interest Expense———790,917USD442,689USD0USD31,623USD77,107USD
    Non Operating Income Net Other———790,917USD441,116USD-31,125USD55,541USD16,149USD
    Net Income Applicable To Common Shares———1,027,775USD7,454,319USD2,588,054USD1,791,141USD1,400,799USD
    Minority Interest————-263,087USD-206,930USD-200,117USD-194,686USD
    Research Development—————0USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets316,989,606USD312,725,628USD276,253,203USD209,509,085USD193,896,201USD205,118,026USD179,028,197USD166,974,064USD
    Total Current Assets283,026,388USD277,354,821USD240,056,951USD171,303,657USD158,707,914USD167,153,858USD158,836,633USD147,499,305USD
    Other Current Assets3,030,661USD162,215,881USD145,870,777USD114,130,193USD105,624,360USD107,023,147USD113,824,133USD104,409,227USD
    Total Liabilities256,832,860USD———————
    Total Current Liabilities248,448,743USD248,108,968USD216,348,490USD152,115,177USD143,316,515USD155,678,621USD146,106,495USD135,865,954USD
    Total Stockholder Equity60,156,746USD55,013,415USD48,490,171USD45,757,805USD42,207,959USD39,274,264USD30,441,632USD28,506,309USD
    Total Equity Including Noncontrolling Interest60,156,746USD———————
    Short Long Term Debt1,686,507USD———————
    Long Term Debt3,564,666USD———————
    Deferred Revenue148,196,011USD———————
    Net Receivables103,167,960USD94,593,821USD73,118,523USD49,644,417USD41,330,370USD53,283,690USD34,245,518USD32,796,871USD
    Property Plant Equipment Net7,261,714USD7,530,168USD7,627,433USD7,387,402USD3,691,454USD3,818,533USD3,950,897USD4,039,103USD
    Goodwill4,487,637USD———————
    Intangible Assets20,838,025USD21,675,898USD22,346,213USD23,341,906USD23,682,758USD25,151,765USD12,239,717USD11,561,703USD
    Accounts Payable97,675,379USD87,539,193USD70,542,803USD39,441,663USD39,477,356USD48,914,973USD34,330,217USD35,349,723USD
    Short Term Debt890,846USD871,495USD2,614,619USD583,773USD490,648USD472,007USD448,008USD424,366USD
    Common Stock57,902USD56,733USD56,022USD55,978USD55,346USD55,082USD54,358USD54,324USD
    Retained Earnings27,275,066USD20,518,529USD15,079,611USD13,716,994USD11,501,859USD10,114,098USD7,527,998USD6,155,126USD
    Total Liab—257,712,213USD227,763,032USD163,751,280USD151,688,242USD165,843,762USD148,586,565USD138,467,755USD
    Other Current Liab—159,698,280USD143,191,068USD112,089,741USD103,348,511USD106,291,641USD111,328,270USD100,091,865USD
    Capital Stock—56,733USD56,022USD55,978USD55,346USD55,082USD54,358USD54,324USD
    Good Will—4,487,637USD4,487,637USD4,487,637USD4,487,637USD5,512,637USD0USD—
    Cash—20,545,119USD21,067,651USD7,529,047USD11,753,184USD6,847,021USD10,766,982USD10,293,207USD
    Cash And Short Term Investments—20,545,119USD21,067,651USD7,529,047USD11,753,184USD6,847,021USD10,766,982USD10,293,207USD
    Current Deferred Revenue—158,112,295USD———104,291,641USD111,328,270USD-35,349,723USD
    Net Debt—-14,625,045USD-7,038,490USD-1,449,822USD-9,031,460USD-4,018,510USD-7,838,904USD-7,267,040USD
    Short Long Term Debt Total—5,920,074USD14,029,161USD6,079,225USD2,721,724USD2,828,511USD2,928,078USD3,026,167USD
    Property Plant Equipment Gross—10,951,974USD10,892,275USD10,508,018USD6,982,902USD7,007,309USD7,037,826USD7,028,780USD
    Accumulated Other Comprehensive Income—0USD0USD0USD0USD0USD0USD0USD
    Common Stock Shares Outstanding—61,022,060shares61,624,326shares61,770,520shares57,872,318shares55,142,511shares55,527,689shares56,051,960shares
    Non Current Assets Total—35,370,807USD36,196,252USD38,205,428USD35,188,287USD37,964,168USD20,191,564USD19,474,759USD
    Non Current Liabilities Total—9,603,245USD11,414,542USD11,636,103USD8,371,727USD10,165,141USD2,480,070USD2,601,801USD
    Non Current Liabilities Other—4,554,666USD6,140,651USD6,140,651USD6,140,651USD7,808,637USD——
    Net Working Capital—29,245,853USD23,708,461USD19,188,480USD15,391,399USD11,475,237USD12,730,138USD11,633,351USD
    Unclassified Non Current Assets—1,677,104USD1,734,969USD——3,481,233USD4,000,950USD—
    Unclassified Current Liabilities—-158,112,295USD———-104,291,641USD-111,328,270USD—
    Unclassified Non Current Liabilities—5,048,579USD5,273,891USD5,495,452USD2,231,076USD2,356,504USD2,480,070USD2,601,801USD
    Unclassified Equity—34,381,420USD33,298,516USD31,928,855USD30,595,408USD29,050,002USD22,804,918USD22,242,535USD
    Non Currrent Assets Other———2,988,483USD3,326,438USD——3,873,953USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets276,253,203USD179,028,197USD146,598,849USD108,244,253USD84,050,793USD67,833,506USD53,548,346USD36,177,708USD
    Intangible Assets22,346,213USD12,239,717USD8,814,327USD5,656,722USD4,086,961USD3,699,033USD3,816,232USD2,115,933USD
    Other Current Assets145,870,777USD113,824,133USD95,963,072USD83,328,172USD63,546,099USD49,619,077USD1,413,208USD27,218,405USD
    Total Liab227,763,032USD148,586,565USD122,111,468USD91,950,958USD71,062,990USD54,597,441USD34,246,831USD27,288,471USD
    Total Stockholder Equity48,490,171USD30,441,632USD24,487,381USD16,293,295USD12,987,803USD13,236,065USD19,301,515USD9,096,167USD
    Other Current Liab143,191,068USD111,328,270USD92,282,124USD80,189,113USD61,283,914USD48,100,951USD1,523,604USD25,960,974USD
    Common Stock56,022USD54,358USD53,452USD52,650USD52,095USD50,252USD48,578USD46,441USD
    Capital Stock56,022USD54,358USD53,452USD52,650USD52,095USD50,252USD48,578USD46,441USD
    Retained Earnings15,079,611USD7,527,998USD3,712,091USD-2,746,636USD-3,774,411USD-1,053,077USD8,088,485USD579,582USD
    Good Will4,487,637USD0USD——————
    Cash21,067,651USD10,766,982USD16,994,705USD9,708,238USD7,387,156USD7,829,453USD9,663,746USD5,615,073USD
    Cash And Short Term Investments21,067,651USD10,766,982USD16,994,705USD9,708,238USD7,387,156USD7,829,453USD9,663,746USD5,615,073USD
    Total Current Assets240,056,951USD158,836,633USD129,180,118USD97,717,401USD74,327,195USD57,960,627USD47,877,449USD33,178,285USD
    Total Current Liabilities216,348,490USD146,106,495USD119,183,390USD88,639,181USD67,389,804USD50,583,843USD34,246,831USD27,288,471USD
    Net Debt-7,038,490USD-7,838,904USD-13,682,928USD-6,035,053USD-3,373,558USD-3,495,219USD-9,663,746USD-5,615,073USD
    Short Term Debt2,614,619USD448,008USD383,699USD361,408USD340,412USD320,636USD1,523,604USD—
    Short Long Term Debt Total14,029,161USD2,928,078USD3,311,777USD3,673,185USD4,013,598USD4,334,234USD——
    Net Receivables73,118,523USD34,245,518USD16,222,341USD4,680,991USD3,393,940USD512,097USD891,936USD337,303USD
    Accounts Payable70,542,803USD34,330,217USD26,517,567USD8,088,660USD5,765,478USD2,162,256USD1,523,604USD1,327,497USD
    Property Plant Equipment Net7,627,433USD3,950,897USD4,304,674USD4,870,130USD5,636,636USD6,173,846USD937,185USD883,490USD
    Property Plant Equipment Gross10,892,275USD7,037,826USD7,023,772USD4,870,130USD5,636,636USD6,173,846USD937,185USD883,490USD
    Accumulated Other Comprehensive Income0USD0USD0USD0USD0USD0USD0USD-1,087,308USD
    Common Stock Shares Outstanding59,648,531shares55,588,459shares54,162,485shares52,933,255shares50,975,794shares49,272,494shares54,550,369shares51,986,505shares
    Non Current Assets Total36,196,252USD20,191,564USD17,418,731USD10,526,852USD9,723,598USD9,872,879USD5,670,897USD2,999,423USD
    Non Current Liabilities Total11,414,542USD2,480,070USD2,928,078USD3,311,777USD3,673,186USD4,013,598USD32,723,227USD0USD
    Non Current Liabilities Other6,140,651USD——3,311,777USD—4,013,598USD——
    Net Working Capital23,708,461USD12,730,138USD9,996,728USD9,078,220USD6,937,391USD7,376,784USD13,630,618USD5,889,814USD
    Unclassified Non Current Assets1,734,969USD4,000,950USD———-4,324,682USD—-3,006,927USD
    Unclassified Non Current Liabilities5,273,891USD2,480,070USD2,928,078USD—3,673,186USD—32,723,227USD—
    Unclassified Equity33,298,516USD22,804,918USD20,668,386USD19,084,631USD16,658,024USD14,338,638USD11,265,874USD9,661,011USD
    Current Deferred Revenue—111,328,270USD92,282,124USD80,189,113USD61,283,914USD48,100,951USD32,723,227USD25,960,974USD
    Unclassified Current Liabilities—-111,328,270USD-92,282,124USD-80,189,113USD-61,283,914USD-48,100,951USD-3,047,208USD-25,960,974USD
    Non Currrent Assets Other——4,299,730USD-10,526,852USD1USD-9,872,879USD-4,753,417USD2,999,423USD
    Inventory———80,189,113USD61,283,914USD48,100,951USD35,908,559USD26,050,668USD
    Treasury Stock———-150,000USD—-150,000USD-150,000USD-150,000USD
    Net Tangible Assets———10,636,573USD8,900,841USD9,537,032USD15,748,370USD6,980,234USD
    Unclassified Current Assets———-80,189,113USD-61,283,914USD-48,100,951USD—-26,043,164USD
    Other Assets—————4,324,682USD917,480USD7,504USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income5,438,918USD1,362,617USD2,215,135USD1,387,761USD2,586,100USD1,372,872USD1,436,837USD697,102USD
    Depreciation2,636,156USD2,207,277USD2,190,420USD2,120,097USD1,801,003USD1,703,338USD1,565,621USD1,439,622USD
    Stock Based Compensation1,284,003USD1,369,749USD1,265,591USD954,400USD672,318USD697,001USD573,499USD670,138USD
    Other Non Cash Items206,765USD206,257USD165,692USD110,669USD109,168USD107,689USD106,233USD104,798USD
    Change To Account Receivables-21,475,298USD-22,822,812USD-7,913,172USD10,901,151USD-19,038,172USD287,740USD-7,132,738USD9,683,440USD
    Change In Working Capital9,162,051USD41,691,282USD577,654USD-1,086,821USD-11,721,483USD10,559,295USD-24,048,183USD17,493,909USD
    Total Cash From Operating Activities18,785,758USD48,090,696USD6,752,447USD3,640,901USD-6,033,177USD14,313,198USD-20,162,771USD20,552,194USD
    Capital Expenditures-1,675,338USD-1,657,871USD-2,182,804USD-1,809,680USD-2,443,855USD-2,400,835USD-2,447,822USD-2,366,964USD
    Free Cash Flow17,110,420USD46,432,825USD4,569,643USD1,831,221USD-8,477,032USD11,912,363USD-22,610,593USD18,185,230USD
    Total Cashflows From Investing Activities-2,075,340USD-1,657,871USD-2,182,804USD-1,809,680USD-4,443,855USD-2,400,835USD-2,447,822USD-2,366,964USD
    Total Cash From Financing Activities-2,199,677USD0USD69,120USD591,534USD-375,786USD-134,550USD-355,695USD24,000USD
    Sale Purchase Of Stock-199,677USD0USD0USD0USD-375,786USD-134,550USD-360,495USD0USD
    Change In Cash14,510,740USD46,432,825USD4,638,763USD2,422,755USD-10,852,818USD11,777,813USD-22,966,288USD18,209,230USD
    Begin Period Cash Flow164,984,711USD118,551,886USD113,913,123USD111,490,368USD122,343,186USD110,565,373USD133,531,661USD115,322,431USD
    End Period Cash Flow179,495,451USD164,984,711USD118,551,886USD113,913,123USD111,490,368USD122,343,186USD110,565,373USD133,531,661USD
    Other Cashflows From Investing Activities-1,808,876USD-1,067,292USD-1,729,248USD-1,723,418USD-2,365,204USD-2,284,101USD-2,325,781USD-2,222,297USD
    Other Cashflows From Financing Activities-2,000,000USD—69,120USD591,534USD——4,800USD24,000USD
    Unclassified Investing Cash Flow1,408,874USD1,067,292USD3,912,052USD3,533,098USD4,809,059USD4,684,936USD4,773,603USD4,589,261USD
    Unclassified Operating Cash Flow—1,253,514USD——————
    Investments——-2,182,804USD-1,809,680USD-4,443,855USD-2,400,835USD-2,447,822USD-2,366,964USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income7,551,613USD3,815,907USD6,458,727USD1,027,775USD-2,721,334USD-9,141,562USD7,454,319USD2,588,054USD
    Depreciation8,318,797USD5,994,986USD4,026,578USD2,909,612USD2,497,918USD2,124,762USD1,483,140USD1,089,521USD
    Stock Based Compensation4,262,058USD2,604,589USD2,853,643USD2,277,717USD2,280,931USD2,971,777USD2,528,613USD1,366,944USD
    Other Non Cash Items2,857,767USD422,103USD394,951USD378,817USD331,027USD614,289USD-1,573USD-6,813USD
    Change To Account Receivables-38,873,005USD-16,437,194USD-11,688,082USD-1,707,084USD-3,758,299USD237,077USD-554,633USD-171,780USD
    Change In Working Capital29,460,632USD9,810,755USD18,186,455USD18,724,043USD12,839,647USD16,289,073USD-603,997USD10,958,263USD
    Total Cash From Operating Activities52,450,867USD22,947,120USD27,620,624USD25,317,964USD15,228,189USD13,775,819USD9,950,526USD15,995,969USD
    Capital Expenditures-1,209,048USD-9,488,702USD-7,048,678USD-4,091,683USD-2,679,664USD-3,344,855USD-463,716USD-1,594,985USD
    Free Cash Flow51,241,819USD13,458,418USD20,571,946USD21,226,281USD12,548,525USD10,430,964USD9,486,810USD14,400,984USD
    Total Cashflows From Investing Activities-10,094,210USD-9,488,702USD-7,048,678USD-4,091,683USD-2,679,664USD-3,344,855USD-3,237,134USD-1,594,985USD
    Total Cash From Financing Activities284,868USD-466,245USD-1,118,284USD-666,018USD192,141USD-72,865USD430,919USD100,000USD
    Sale Purchase Of Stock-375,786USD-495,045USD-1,127,884USD0USD0USD-245,425USD430,919USD100,000USD
    Change In Cash42,641,525USD12,992,173USD19,453,662USD21,226,281USD12,740,666USD10,358,099USD13,906,564USD14,500,984USD
    Begin Period Cash Flow122,343,186USD109,351,013USD89,897,351USD68,671,070USD55,930,404USD45,572,305USD31,665,741USD17,164,757USD
    End Period Cash Flow164,984,711USD122,343,186USD109,351,013USD89,897,351USD68,671,070USD55,930,404USD45,572,305USD31,665,741USD
    Other Cashflows From Investing Activities-8,885,162USD-9,053,801USD-6,786,122USD-3,986,497USD-2,351,098USD-1,961,544USD-2,773,420USD-1,337,923USD
    Other Cashflows From Financing Activities284,868USD28,800USD9,600USD-4,091,683USD192,141USD172,560USD430,919USD100,000USD
    Investments—-9,488,702USD-6,507,660USD-4,091,683USD-2,679,664USD-3,344,855USD-3,237,134USD-1,594,985USD
    Unclassified Investing Cash Flow—18,542,503USD13,293,782USD8,078,180USD5,030,762USD5,306,399USD3,237,136USD2,932,908USD
    Unclassified Operating Cash Flow——-4,299,730USD—————
    Change To Liabilities———2,323,182USD16,786,185USD741,533USD196,107USD11,726,944USD
    Cash And Cash Equivalents Changes———21,226,281USD—10,358,099USD13,906,564USD14,500,984USD
    Unclassified Financing Cash Flow———3,425,665USD————
    Change To Inventory————-3,603,222USD-741,533USD-196,107USD-596,901USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductBreakage Revenue75,632USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOther Revenue562,398USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductPharma Industry14,649,133USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductPlasma Industry13,040,540USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSettlement Revenue0USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductBreakage Revenue112,046USD0001683168-26-003762
    Q1 2026Quarterly · 2026-03-31ProductOther Revenue610,361USD0001683168-26-003762
    Q1 2026Quarterly · 2026-03-31ProductPharma Industry15,679,452USD0001683168-26-003762
    Q1 2026Quarterly · 2026-03-31ProductPlasma Industry11,748,611USD0001683168-26-003762
    Q1 2026Quarterly · 2026-03-31ProductSettlement Revenue0USD0001683168-26-003762
    FY 2025Yearly · 2025-12-31ProductBreakage Revenue474,709USD0001683168-26-002180
    FY 2025Yearly · 2025-12-31ProductOther Revenue2,523,905USD0001683168-26-002180
    FY 2025Yearly · 2025-12-31ProductPharma Industry33,888,631USD0001683168-26-002180
    FY 2025Yearly · 2025-12-31ProductPlasma Industry45,615,640USD0001683168-26-002180
    FY 2025Yearly · 2025-12-31ProductSettlement Revenue0USD0001683168-26-002180
    Q2 2025Quarterly · 2025-06-30ProductBreakage Revenue54,934USD0001683168-25-005680
    Q2 2025Quarterly · 2025-06-30ProductOther Revenue580,523USD0001683168-25-005680
    Q2 2025Quarterly · 2025-06-30ProductPharma Industry7,753,906USD0001683168-25-005680
    Q2 2025Quarterly · 2025-06-30ProductPlasma Industry10,743,924USD0001683168-25-005680
    Q2 2025Quarterly · 2025-06-30ProductSettlement Revenue0USD0001683168-25-005680
    Q1 2025Quarterly · 2025-03-31ProductBreakage Revenue101,000USD0001683168-25-003316
    Q1 2025Quarterly · 2025-03-31ProductOther Revenue569,616USD0001683168-25-003316
    Q1 2025Quarterly · 2025-03-31ProductPharma Industry8,618,653USD0001683168-25-003316
    Q1 2025Quarterly · 2025-03-31ProductPlasma Industry9,409,880USD0001683168-25-003316
    Q1 2025Quarterly · 2025-03-31ProductSettlement Revenue0USD0001683168-25-003316
    Q4 2024Quarterly · 2024-12-31ProductBreakage Revenue136,029USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Revenue493,791USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPharma Industry4,313,979USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPlasma Industry10,798,678USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSettlement Revenue30,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductBreakage Revenue242,355USD0001683168-26-002180
    FY 2024Yearly · 2024-12-31ProductOther Revenue1,852,632USD0001683168-26-002180
    FY 2024Yearly · 2024-12-31ProductPharma Industry12,652,412USD0001683168-26-002180
    FY 2024Yearly · 2024-12-31ProductPlasma Industry43,879,508USD0001683168-26-002180
    FY 2024Yearly · 2024-12-31ProductSettlement Revenue30,000USD0001683168-26-002180
    Q3 2024Quarterly · 2024-09-30ProductBreakage Revenue19,331USD0001683168-25-008281
    Q3 2024Quarterly · 2024-09-30ProductOther Revenue542,009USD0001683168-25-008281
    Q3 2024Quarterly · 2024-09-30ProductPharma Industry3,274,888USD0001683168-25-008281
    Q3 2024Quarterly · 2024-09-30ProductPlasma Industry11,439,534USD0001683168-25-008281
    Q3 2024Quarterly · 2024-09-30ProductSettlement Revenue0USD0001683168-25-008281
    Q2 2024Quarterly · 2024-06-30ProductBreakage Revenue33,995USD0001683168-25-005680
    Q2 2024Quarterly · 2024-06-30ProductOther Revenue383,436USD0001683168-25-005680
    Q2 2024Quarterly · 2024-06-30ProductPharma Industry2,674,901USD0001683168-25-005680
    Q2 2024Quarterly · 2024-06-30ProductPlasma Industry11,273,262USD0001683168-25-005680
    Q2 2024Quarterly · 2024-06-30ProductSettlement Revenue0USD0001683168-25-005680
    Q1 2024Quarterly · 2024-03-31ProductBreakage Revenue53,000USD0001683168-25-003316
    Q1 2024Quarterly · 2024-03-31ProductOther Revenue433,396USD0001683168-25-003316
    Q1 2024Quarterly · 2024-03-31ProductPharma Industry2,388,644USD0001683168-25-003316
    Q1 2024Quarterly · 2024-03-31ProductPlasma Industry10,368,034USD0001683168-25-003316
    Q1 2024Quarterly · 2024-03-31ProductSettlement Revenue0USD0001683168-25-003316
    FY 2023Yearly · 2023-12-31ProductBreakage Revenue74,000USD0001683168-25-001888
    FY 2023Yearly · 2023-12-31ProductOther Revenue1,271,466USD0001683168-25-001888
    FY 2023Yearly · 2023-12-31ProductPharma Industry4,051,037USD0001683168-25-001888
    FY 2023Yearly · 2023-12-31ProductPlasma Industry41,951,659USD0001683168-25-001888
    FY 2023Yearly · 2023-12-31ProductSettlement Revenue29,000USD0001683168-25-001888
    FY 2022Yearly · 2022-12-31ProductOther Revenue288,887USD0001683168-24-001729
    FY 2022Yearly · 2022-12-31ProductPharmaceutical Industry3,007,140USD0001683168-24-001729
    FY 2022Yearly · 2022-12-31ProductPlasma Industry34,737,640USD0001683168-24-001729
    FY 2021Yearly · 2021-12-31ProductOther Revenue184,830USD0001683168-23-001661
    FY 2021Yearly · 2021-12-31ProductPharmaceutical Industry3,361,869USD0001683168-23-001661
    FY 2021Yearly · 2021-12-31ProductPlasma Industry25,918,150USD0001683168-23-001661
    FY 2020Yearly · 2020-12-31ProductOther Revenue392,667USD0001683168-22-001854
    FY 2020Yearly · 2020-12-31ProductPharmaceutical Industry326,699USD0001683168-22-001854
    FY 2020Yearly · 2020-12-31ProductPlasma Industry23,401,068USD0001683168-22-001854
    FY 2019Yearly · 2019-12-31ProductOther Income298,734USD0001683168-21-001067
    FY 2019Yearly · 2019-12-31ProductPharmaceutical Industry7,372,990USD0001683168-21-001067
    FY 2019Yearly · 2019-12-31ProductPlasma Industry26,994,929USD0001683168-21-001067
    FY 2018Yearly · 2018-12-31ProductOther Income25,410USD0001683168-20-001096
    FY 2018Yearly · 2018-12-31ProductPharmaceutical Industry366,442USD0001683168-20-001096
    FY 2018Yearly · 2018-12-31ProductPlasma Industry23,031,823USD0001683168-20-001096

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.